Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study)

NCT00633698 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Elevated Lipoprotein(a) Levels

Interventions

DRUG: Nicotinic acid (niacin)
DRUG: Placebo

Sponsor

Charite University, Berlin, Germany